Pfisterer M, Teetzmann A, Vetter S, Baeßler J, Schreckenberger L, Zaiser J, Stenger M, Bach P. CBD attenuates amygdala response to negative emotional stimuli in individuals with alcohol use disorder - a randomized controlled trial. Psychopharmacology (Berl). 2025 Aug 29. [Epub ahead of print]
Pfisterer M, Zimmermann S, Zaiser J, Gerhardt S, Vollstädt-Klein S, Kiefer F, Bach P. Biomarkers in alcohol use disorder - the promise and pitfalls of neuroimaging drug cue reactivity. Biomarkers in neuropsychiatry. 2025 12:100119.
Zaiser J, Hoffmann S, Zimmermann S, Gessner T, Deck M, Bekier N, Abel M, Radler P, Langejürgen J, Lenz B, Vollstädt-Klein S, Stallkamp J, Kirschbaum C, Kiefer F, Bach P. Individual stress reactivity predicts alcohol craving and alcohol consumption in alcohol use disorder in experimental and real-life settings. Transl Psychiatry. 2025 15(1):226.
Zimmermann S, Teetzmann A, Baeßler J, Schreckenberger L, Zaiser J, Pfisterer M, Stenger M, Bach P. Acute cannabidiol administration reduces alcohol craving and cue-induced nucleus accumbens activation in individuals with alcohol use disorder: the double-blind randomized controlled ICONIC trial. Mol Psychiatry. 2025 30(6):2612-2619. Epub 2024 Dec 12.